DD vs INFU · P/E 127, rev $12.39B vs P/E 25, rev $134.9M
Dupont De Nemours Inc (DD) versus InfuSystems Holdings Inc (INFU) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
InfuSystems Holdings Inc (INFU) is a medical devices company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported INFU revenue for 2024-12-31 was $134.9M. Net income was $2.3M. Revenue was up 7.2% from 2023-12-31 to 2024-12-31. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
DD currently screens at market cap $19.61B and trailing P/E 127.4. INFU currently screens at market cap $186.5M and trailing P/E 25.0.
Not investment advice. Open the DD and INFU stock pages for the full models.
Not investment advice.